Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-12-012641)

Filing Details

Accession Number:: 0001179110-12-012641
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-09 17:39:52
Reporting Period:: 2012-08-07

Filing Date:: 2012-08-09
Accepted Time:: 2012-08-09 17:39:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1034842	Rigel Pharmaceuticals Inc	RIGL	Pharmaceutical Preparations (2834)	943248524

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363984	D Ryan Maynard	Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080	Evp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-07	1,700	$6.49	1,700	No	4	M	Direct
Common Stock	Disposition	2012-08-07	700	$10.60	1,000	No	4	S	Direct
Common Stock	Disposition	2012-08-07	100	$10.61	900	No	4	S	Direct
Common Stock	Disposition	2012-08-07	600	$10.62	300	No	4	S	Direct
Common Stock	Disposition	2012-08-07	300	$10.63	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-08-07	1,700	$0.00	1,700	$6.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
148,300		2019-03-30	No	4	M	Direct

Footnotes

The shares vested monthly over one (1) year from 3/30/09.